Who owns the STATICIN trademark?

The STATICIN trademark is owned by Westwood-Squibb Pharmaceuticals, Inc..

What class is the STATICIN trademark registered in?

The STATICIN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for STATICIN?

The USPTO serial number for STATICIN is 77652701.

What is the registration number for STATICIN?

STATICIN is registered under USPTO registration number 0.

Sealvo

Home Search: STATICINSTATICIN #77652701

Back

Updated Sep 18, 2026·27 searches this week

View on USPTO TSDR Find similar marks

STA

USPTO Trademark Record

ABANDONED

STATICIN

SN 77652701·Reg 0·Filed Jan 20, 2009

Owner Westwood-Squibb Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

STATICIN (Serial No. 77652701), Registration No. 0, is a abandoned US trademark filed on Jan 20, 2009 by Westwood-Squibb Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Conflict Analysis

Full conflict analysis for STATICIN (SN 77652701) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

STATICIN (Reg. #0) is an abandoned US trademark that was filed in 2009 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs....

FILED

Jan 20, 2009

SERIAL

77652701

REG#

REGISTERED

Dec 31, 1969

Filing Information

StatusABANDONED

Filing DateJan 20, 2009

Serial Number77652701

Registration No.0

Registration DateDec 31, 1969

Status DateNov 03, 2009

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: May 18, 1978

First use in commerce: May 18, 1978

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

6 events

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Nov 03, 2009

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

Nov 03, 2009

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND

NON-FINAL ACTION MAILED

Apr 07, 2009

NON-FINAL ACTION MAILED

NON-FINAL ACTION WRITTEN

Apr 06, 2009

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Mar 30, 2009

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Jan 23, 2009

NEW APPLICATION ENTERED

Other Marks by Westwood-Squibb Pharmaceuticals, Inc.

Additional USPTO filings from the same owner.

SEB

SEBUCARE

73793675

WESTWOOD-SQUIBB PHARMACEUTICALS, INC.

ABANDONED

STA

STATICIN

73179716

WESTWOOD-SQUIBB PHARMACEUTICALS, INC.

ABANDONED

MAX

MAXIVATE

73612922

WESTWOOD-SQUIBB PHARMACEUTICALS, INC.

ABANDONED

SEB

SEBUTONE

72194044

WESTWOOD-SQUIBB PHARMACEUTICALS, INC.

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

STA

STATICIN

73179716

WESTWOOD-SQUIBB PHARMACEUTICALS, INC.

ABANDONED

Other Marks by Nadine P. Flynn

Additional USPTO filings handled by the same attorney of record.

IXE

IXEMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

77775355

OTHERS

IXA

IXAMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

77775341

OTHERS

IXA